Main > A2. TRADEMARK. INDEX. Vn-Vz > Vyvanse

Product USA. S

GENERIC NAME This data is not available for free
INDICATION'S Neurology>ADHD>Treat.
MARKETER'S COUNTRY USA
OBSERVATION'S Approved Strengths: 20, 30, 40, 50, 60 & 70 mg
STATUS FDA Approved. USA Patent Expiration: 06.01.2024
UPDATE 01.03.08
COMPANY This data is not available for free
PATENT NUMBER This data is not available for free

Want more information ?
Interested in the hidden information ?
Click here and do your request.


back